RESTORE: Raptiva® (Efalizumab) Evaluation of Safety and Treatment Optimization

Stopped The study was terminated after the EMEA recommended to suspend the marketing authorisation of Raptiva in the EU

Conditions

• Plaque Psoriasis

Sponsor

Merck KGaA, Darmstadt, Germany